Claus Kamby

Postoperative radiotherapy in high-risk postmenopausal breast-cancer patients given adjuvant tamoxifen: Danish Breast Cancer Cooperative Group DBCG 82c randomised trial

Marie Overgaard, Maj‐Britt Jensen, Jens Overgaard et al. · The Lancet · 1999 · 1.6K citations

Breast Oncology, Radiation Therapy, Medicine +8

Randomised phase II trial of pegylated liposomal doxorubicin (DOXIL®/CAELYX®) versus doxorubicin in the treatment of advanced or metastatic soft tissue sarcoma

Ian Judson, John Radford, Martin Harris et al. · European Journal of Cancer · 2001 · 382 citations

Surgical Oncology, Phase Ii Trial, Medicine +8

Serum YKL-40: A new potential marker of prognosis and location of métastases of patients with recurrent breast cancer

Julia S. Johansen, C. Cintin, Morten Buus Jørgensen et al. · European Journal of Cancer · 1995 · 144 citations

Breast Oncology, Medicine, Pathology +8

Electrochemotherapy for large cutaneous recurrence of breast cancer: A phase II clinical trial

Louise Wichmann Matthiessen, Helle Hjorth Johannesen, Helle Westergren Hendel et al. · Acta Oncologica · 2012 · 126 citations · Full text

Extended adjuvant intermittent letrozole versus continuous letrozole in postmenopausal women with breast cancer (SOLE): a multicentre, open-label, randomised, phase 3 trial

Marco Colleoni, Weixiu Luo, Per Karlsson et al. · The Lancet Oncology · 2017 · 120 citations

Breast Oncology, Medicine, Cancer Management +7